HANGZHOU TIGERMED CONSULTING CO LTD revenue for the last year amounted to 8.00 B HKD, the most of which — 4.61 B HKD — came from its highest performing source at the moment, Clinical Trial Technical Services, the year earlier bringing 4.80 B HKD. The greatest contribution to the revenue figure was made by China — last year it brought HANGZHOU TIGERMED CONSULTING CO LTD 4.68 B HKD, and the year before that — 4.19 B HKD.